Close Menu

B. Braun

As part of the collaboration, B. Braun China founded a subsidiary, called B. Braun Precision Medicine Technology (BBPM), that opened in Shanghai in May.

NEW YORK (GenomeWeb) – B. Braun CeGaT, the recently-founded US subsidiary of German genetic diagnostics firm CeGaT and its minority stakeholder B. Braun, will initially offer molecular diagnostic testing services through CeGaT's German laboratory but plans to establish a US lab in the long run.

CeGaT, the Center for Genomics and Transcriptomics, said this week that healthcare product and service provider B. Braun Melsungen has taken a 20 percent stake in the firm.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.